1. Home
  2. HRMY vs ALG Comparison

HRMY vs ALG Comparison

Compare HRMY & ALG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$36.75

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

SELL

Current Price

$147.53

Market Cap

1.9B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
HRMY
ALG
Founded
2017
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
HRMY
ALG
Price
$36.75
$147.53
Analyst Decision
Buy
Buy
Analyst Count
12
4
Target Price
$48.08
★ $203.50
AVG Volume (30 Days)
★ 993.4K
127.6K
Earning Date
11-04-2026
11-02-2026
Dividend Yield
N/A
★ 0.92%
EPS Growth
★ 7.97
N/A
EPS
1.84
★ 4.96
Revenue
$868,453,000.00
★ $1,603,715,000.00
Revenue This Year
$18.17
$6.09
Revenue Next Year
$13.71
$4.51
P/E Ratio
★ $20.01
$29.98
Revenue Growth
★ 21.51
N/A
52 Week Low
$25.90
$133.32
52 Week High
$43.49
$219.88

Technical Indicators

Market Signals
Indicator
HRMY
ALG
Relative Strength Index (RSI) 50.13 40.34
Support Level $36.74 N/A
Resistance Level $39.40 $168.92
Average True Range (ATR) 1.50 4.50
MACD 0.17 0.47
Stochastic Oscillator 80.36 59.76

Price Performance

Historical Comparison
HRMY
ALG

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.

Share on Social Networks: